ANNOUNCED AS TEMPORARYYes
In Decree No. ПП–2595 is stated that it would achieve its goal by enhancing the local manufacturing of pharmaceutical production with high value added and in high demand on foreign markets. These perspective goods are to be prepared on the basis of mineral, chemical, and biological raw materials.
Specifically, Decree No. ПП–2595 exempts from the payment of import tariffs the technological equipment, components and spare parts that are not produced in the country and are imported in the framework of the supported projects.
According to Decree No. ПП–2595, the mentioned state intervention is to remain in force until 1 January 2021.
Decree No. ПП–2595 enters into force on 26 December 2016.
Furthermore, Article 2 of the presidential decree approves a list of investment projects for the period 2016--2020 for the production of export-oriented pharmaceutical products with high added value, prepared on the basis of mineral, chemical, and biological raw materials. Please note that this list is neither disclosed in the official legal source nor in other publicly available source. As a result, no separate government intervention was reported here.
⚑ Please report this page in case you detect an inaccuracy in its content.